Core Viewpoint - Qingdao Guoen Technology Co., Ltd. is preparing for its listing on the Hong Kong Stock Exchange, focusing on new chemical materials and gelatin, with a strong emphasis on both the chemical and health industries [1]. Group 1: Company Overview - Guoen Technology specializes in the research, production, and sales of products for the chemical and health industries, serving clients in sectors such as automotive, renewable energy, and healthcare [3]. - The company is recognized as the second-largest producer of organic polymer modified materials and organic polymer composite materials in China, holding a market share of 2.5% as of 2024 [4]. Group 2: Product and Market Position - In the chemical sector, Guoen's product range includes upstream green petrochemical materials and midstream organic polymer modified materials, catering to diverse applications in electronics, automotive, and energy storage [4]. - In the health sector, the company focuses on the natural collagen industry, with its subsidiary Dongbao Bio leveraging a vertically integrated strategy to cover the entire value chain from collagen to end products [5]. Group 3: Financial Performance - The company's revenue for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 were approximately RMB 134.06 billion, RMB 174.39 billion, RMB 191.88 billion, and RMB 174.44 billion, respectively [6]. - The net profit for the same periods was RMB 7.24 billion, RMB 5.4 billion, RMB 7.21 billion, and RMB 7.21 billion [6].

Group 1: Company Overview - Qingdao Guoen Technology Co., Ltd. (002768.SZ) is focused on new chemical materials and gelatin, collagen upstream and downstream products, and has passed the listing hearing on the Hong Kong Stock Exchange [1] - The company serves the chemical and health industries, primarily engaged in the R&D, production, and sales of products for industrial and commercial use [3] Group 2: Industry Position - In the chemical industry, Guoen Technology is the second-largest company in China for organic polymer modified materials and organic polymer composite materials, with a market share of 2.5% as of 2024 [4] - The company is also the largest producer of polystyrene in China by production capacity as of 2024 [4] Group 3: Product and Market Focus - Guoen Technology focuses on the natural collagen industry, with a vertical integration strategy that covers collagen peptide derivatives to end products [5] - The company is the second-largest producer of bone gelatin in China and the second-largest domestic brand in the hollow capsule production industry as of 2024 [6] Group 4: Market Growth - The market size for organic polymer modified materials and organic polymer composite materials is projected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion in 2024, with a compound annual growth rate (CAGR) of 15.7% [6] - The market is expected to continue growing at a CAGR of 14.1% from 2025 to 2029, reaching RMB 1,037.5 billion by 2029 [6] Group 5: Financial Performance - Guoen Technology's revenues for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 were approximately RMB 13.41 billion, RMB 17.44 billion, RMB 19.19 billion, and RMB 17.44 billion respectively [6][7] - The company reported net profits of RMB 724 million, RMB 540 million, RMB 721 million, and RMB 721 million for the same periods [6][8]

格隆汇1月14日丨国恩股份(002768.SZ)公布，根据本次发行并上市的安排，公司按照有关规定在香港联 交所网站刊登本次发行聆讯后资料集，该聆讯后资料集为公司根据香港联交所、香港证券及期货事务监 察委员会（简称"香港证监会"）的要求而刊发，刊发目的仅为提供资讯予香港公众人士和合资格的投资 者。同时，该聆讯后资料集为草拟版本，其所载资料可能会适时作出更新和变动。 ...

详见公司 2026 年 1 月 10 日披露于《证券时报》《证券日报》《中国证券报》 《上海证券报》和巨潮资讯网（www.cninfo.com.cn）上的《关于申请发行境外 上市外资股（H 股）并上市的进展公告》（公告编号：2026-001）。 根据本次发行并上市的安排，公司按照有关规定在香港联交所网站刊登本 次发行聆讯后资料集，该聆讯后资料集为公司根据香港联交所、香港证券及期 货事务监察委员会（以下简称"香港证监会"）的要求而刊发，刊发目的仅为 提供资讯予香港公众人士和合资格的投资者。同时，该聆讯后资料集为草拟版 本，其所载资料可能会适时作出更新和变动。 股票代码：002768 股票简称：国恩股份 公告编号：2026-004 青岛国恩科技股份有限公司 关于刊发境外上市外资股（H 股）发行聆讯后资料集 的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 青岛国恩科技股份有限公司（以下简称"公司"）正在进行申请发行境外 上市外资股（H 股）并在香港联合交易所有限公司（以下简称"香港联交所"） 主板挂牌上市（以下简称"本次发行并上市"）的相关工作。 2025 ...

Group 1 - Qingdao Guoen Technology Co., Ltd. has passed the listing hearing on the Hong Kong Stock Exchange [1]

倘於適當時候向香港公眾人士提出要約或邀請，有意投資者務請僅依據送呈香港公司註冊處處長登記的本 公司招股章程作出投資決定，招股章程的文本將於發售期內向公眾提供。 (a) 本文件僅為向香港公眾人士提供有關本公司的資料，概無任何其他目的。投資者不應根據本文件中 的資料作出任何投資決定； (b) 在聯交所網站登載本文件或補充、修訂或更換附頁，並不引起本公司、其獨家保薦人、整體協調 人、顧問及包銷團成員須在香港或任何其他司法管轄區進行發售活動的任何責任。本公司最終會否 進行發售仍屬未知之數； (c) 本文件或補充、修訂或更換附頁的內容未必會在實際最終的上市文件內全部或部分轉載； (d) 本聆訊後資料集並非最終的上市文件，本公司可能不時根據聯交所證券上市規則作出更新或修訂； (e) 本文件並不構成向任何司法管轄區的公眾人士提呈出售任何證券的招股章程、發售通函、通知、通 告、小冊子或廣告，亦非邀請公眾人士提出認購或購買任何證券的要約，且不旨在邀請公眾人士提 出認購或購買任何證券的要約； (f) 本文件不得被視為誘使認購或購買任何證券，亦無意構成該等勸誘； (g) 本公司或其任何聯屬公司、保薦人、整體協調人、顧問或包銷團成員 ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of Qingdao Gon Technology Co., Ltd. 青島國恩科技股份有限公司 (the "Company") (A joint stock co ...

证券之星消息，1月13日塑料板块较上一交易日下跌3.01%，瑞华泰领跌。当日上证指数报收于4138.76， 下跌0.64%。深证成指报收于14169.4，下跌1.37%。塑料板块个股涨跌见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入(元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 001255 博菲电气 | | 8455.74万 | 45.40% | -5229.15万 | -28.08% | -3226.59万 | -17.33% | | 000973 佛塑科技 | | 3338.29万 | 4.21% | -1275.44万 | -1.61% | -2062.85万 | -2.60% | | 001359 | 平安电工 | 2974.51万 | 12.98% | -31.69万 | -0.14% | -2942.82万 | -12.84% | | 601026 道生天合 | | 2928.08万 | 9.47% | -66.15万 | -0.21% | ...

Group 1 - The core viewpoint of the article highlights the recent IPO activities in the Shanghai Stock Exchange, Shenzhen Stock Exchange, and Hong Kong Stock Exchange, with a focus on the performance of newly listed companies and their market valuations [2][8][12] - In the Shanghai Stock Exchange, only one company, Shaanxi Tourism, was listed during the period, with its stock price increasing by 72.18% from the issue price, reaching a market capitalization of approximately 10.7 billion yuan [3][2] - The Hong Kong Stock Exchange saw a more active IPO environment with seven companies listed, including notable performers like Zhipu Huazhang and MiniMax, which saw significant stock price increases of 79.35% and 141.21% respectively [9][10][11] Group 2 - Zhipu Huazhang, an AI company, achieved a market capitalization of approximately 91.7 billion HKD after a 79.35% increase in stock price [9] - MiniMax, another AI-focused company, experienced a remarkable 141.21% increase in stock price, leading to a market capitalization of around 123.1 billion HKD [10] - Other companies like Tian Shu Zhi Xin and Jing Feng Medical also reported substantial stock price increases, indicating a strong interest in tech and healthcare sectors [10][11] Group 3 - Several companies submitted IPO applications during the period, including Zhejiang Borui Biopharmaceutical and Hangzhou Deshi Biotechnology, indicating ongoing interest in the biotech sector [16][26] - The financial data of these companies show varying revenue and profit trends, with Borui Biopharmaceutical projecting revenues of 12.57 billion yuan and 16.23 billion yuan for 2023 and 2024 respectively [24][26] - Deshi Biotech reported revenues of 52.84 million yuan and 70.35 million yuan for the same periods, highlighting the growth potential in the medical imaging sector despite initial losses [27] Group 4 - Companies like Xizi Health and Sanisen Di are focusing on expanding their market presence in the health and nutrition sectors, with Xizi Health projecting revenues of 14.47 billion yuan and 16.92 billion yuan for 2023 and 2024 [36][38] - Sanisen Di aims to enhance its product competitiveness and expand its sales network, reflecting a trend towards innovation in the toy industry [39] - The financial performance of these companies indicates a mix of growth and challenges, with Xizi Health showing a profit increase while Sanisen Di is still working towards profitability [40][38] Group 5 - The article also discusses the performance of established companies like Laoxiangji, which is the largest Chinese fast-food brand, reporting revenues of 45.28 billion yuan in 2022 and projected growth in subsequent years [44] - Laoxiangji's market strategy includes optimizing its supply chain and expanding its store network, which is crucial for maintaining its competitive edge in the fast-food industry [43] - The financial outlook for Laoxiangji shows a steady increase in revenue and profit, indicating a strong market position despite potential risks associated with brand recognition and operational challenges [45][44]

Group 1 - The core point of the news is that Guoen Co., Ltd. experienced a stock price increase of 5.07%, reaching 59.47 CNY per share, with a trading volume of 280 million CNY and a turnover rate of 2.74%, resulting in a total market capitalization of 16.131 billion CNY [1] - Guoen Co., Ltd. is located in Qingdao, Shandong Province, and was established on December 22, 2000. The company was listed on June 30, 2015, and its main business involves the research, production, and sales of modified plastic particles and various modified plastic products [1] - The revenue composition of Guoen Co., Ltd. includes: organic polymer modified materials (50.38%), green petrochemical materials and new materials (20.11%), organic polymer composite materials (17.71%), others (8.02%), biomedicine and health products (2.05%), and gelatin, collagen, and their derivatives (1.73%) [1] Group 2 - According to data, one fund under China Europe Fund holds a significant position in Guoen Co., Ltd. The China Europe Chemical Industry Mixed Fund A (024640) held 323,000 shares in the third quarter, accounting for 6.24% of the fund's net value, making it the third-largest holding [2] - The China Europe Chemical Industry Mixed Fund A (024640) was established on August 13, 2025, with a latest scale of 43.6124 million CNY. The fund has achieved a return of 4.28% this year, ranking 3287 out of 9012 in its category, and a cumulative return of 28.62% since inception [2]